Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE).
Journal: American journal of respiratory and critical care medicine
Published: March 05, 2025
Efficacy of Reslizumab Treatment in Exacerbation-Prone Patients with Severe Eosinophilic Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 13, 2019
In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: November 11, 2019
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Modeling of Weight-Based Intravenous Reslizumab Dosing.
Journal: Journal of clinical pharmacology
Published: October 04, 2019
Reslizumab as add-on therapy in patients with refractory asthma.
Journal: BMJ open respiratory research
Published: September 10, 2019
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
Journal: The Lancet. Respiratory medicine
Published: June 25, 2019
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 08, 2019
Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 14, 2018
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma.
Journal: American journal of respiratory and critical care medicine
Published: October 23, 2018
Early decreases in blood eosinophil levels with reslizumab.
Journal: The Journal of allergy and clinical immunology
Published: June 20, 2018
Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 18, 2017
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 03, 2017
Last Updated: 09/26/2026